Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19.
Braz J Psychiatry July 26, 2022 DOI: 10.47626/1516-4446-2022-2541 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Topics | Ayahuasca |
| Key points | Proposes that ayahuasca's modulation of the sigma-1 receptor could offer a therapeutic approach for COVID-19 by affecting viral replication and inflammation. |
Abstract
Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19.